NCI Awards GeneGo $1M Phase II SBIR Grant to Discover Breast Cancer Biomarkers | GenomeWeb
NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded GeneGo a phase II SBIR grant worth $1 million over two years related to help it discover breast cancer biomarkers, GeneGo said today.
The research program includes a large-scale gene-expression and genotyping study to be conducted at Mayo Clinic. GeneGo will use its MetaCore data-mining program for data analysis.
GeneGo said that in phase I of the grant it performed a network analysis of previously published microarray expression data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.